Cancer/testis antigen 1 (92-100)

Cancer/testis antigen 1 (92-100) is a synthetic peptide fragment derived from the cancer/testis antigen 1 (CTAG1), also known as NY-ESO-1, encompassing amino acid residues 92 to 100 of the full-length protein. As a member of the cancer/testis antigen family, this peptide is exclusively expressed in various tumor types and germ cells of the testis, but not in normal somatic tissues, making it a valuable target for tumor immunology research. The 92-100 region represents a well-characterized epitope recognized by cytotoxic T lymphocytes, facilitating its use in studies of antigen processing, immune recognition, and peptide-based assay development. Researchers utilize this peptide to dissect the molecular interactions underlying tumor-specific immune responses and to support the design of experimental immunotherapeutics.

Immunological Assay Development: Cancer/testis antigen 1 (92-100) is widely used in the development and optimization of immunological assays, particularly those aimed at detecting antigen-specific T cell responses. Its defined sequence enables precise evaluation of T cell activation and cytokine release in ex vivo or in vitro systems, supporting the quantification and functional characterization of NY-ESO-1-reactive T lymphocytes. These assays are crucial for monitoring immune responses in cancer research, vaccine development, and adoptive cell transfer protocols, providing a reliable tool for assessing the immunogenicity of tumor-associated antigens.

Epitope Mapping Studies: The peptide serves as a critical reagent in epitope mapping experiments aimed at delineating the antigenic determinants recognized by T cell receptors or antibodies. By incorporating the 92-100 epitope into mapping platforms, investigators can identify the specificity and breadth of immune recognition directed against cancer/testis antigens. Such studies are fundamental to understanding the molecular basis of tumor immunity and inform the rational design of peptide-based vaccines and diagnostic reagents.

T Cell Functional Analysis: Researchers employ this peptide in functional assays to stimulate antigen-specific cytotoxic T lymphocytes (CTLs) and analyze their effector functions, such as cytolytic activity and cytokine secretion. The use of a well-defined epitope allows for the controlled activation of T cells in vitro, facilitating studies on T cell receptor signaling, immune synapse formation, and the mechanisms underlying tumor cell recognition and elimination. These insights are instrumental in advancing the field of tumor immunology and immunotherapeutic strategy development.

Antigen Presentation Investigations: Cancer/testis antigen 1 (92-100) is utilized in studies examining the processing and presentation of tumor antigens by major histocompatibility complex (MHC) molecules. By pulsing antigen-presenting cells with this peptide, investigators can assess the efficiency of peptide loading, MHC restriction, and the subsequent activation of T cell subsets. These experiments contribute to a deeper understanding of antigen presentation pathways and their modulation in the tumor microenvironment, which is essential for the improvement of immunotherapeutic approaches.

Peptide-Based Screening Platforms: The 92-100 fragment is incorporated into peptide libraries and screening arrays designed for high-throughput identification of antigen-specific immune responses. Its inclusion enables the systematic evaluation of T cell repertoires, the discovery of cross-reactive epitopes, and the profiling of immune signatures associated with disease progression or therapeutic intervention. Such platforms are valuable for biomarker discovery and the preclinical assessment of candidate immunomodulatory agents targeting cancer/testis antigens.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes